Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
16 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-wide-ranging-one-year-data-from-phase-3-cahtalyst-pediatric-study-at-pediatric-endocrine-society-2025-annual-meeting-302457277.html
16 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-data-adding-to-the-growing-body-of-evidence-demonstrating-functional-and-quality-of-life-improvements-in-patients-with-tardive-dyskinesia-302457312.html
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-findings-contributing-to-the-growing-body-of-evidence-on-the-impact-of-high-dose-glucocorticoids-on-clinical-outcomes-in-congenital-adrenal-hyperplasia-302455617.html
08 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-new-results-from-exploratory-analyses-of-the-phase-3-cahtalyst-pediatric-study-demonstrating-crenessity-reduces-glucocorticoid-dosing-while-maintaining-or-improving-androstenedione-across-patient-302449317.html
06 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/neurocrine-holds-branded-tardive-dyskinesia-push-help-wilson-phillips-star
06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-upcoming-investor-conferences-in-may-302447740.html
ABOUT THIS PAGE